As of April 16, 2025, Immatics (IMTX) has a market cap of $0.53 billion USD. According to our data, Immatics is ranked No.5892 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 16, 2025 | $0.53 B |
-38.54%
|
Dec 31, 2024 | $0.86 B |
-32.48%
|
Dec 29, 2023 | $1.28 B |
20.90%
|
Dec 30, 2022 | $1.06 B |
-35.19%
|
Dec 31, 2021 | $1.63 B |
24.56%
|
Dec 31, 2020 | $1.31 B |
3.75%
|
Dec 31, 2019 | $1.26 B |
6.12%
|
Dec 31, 2018 | $1.19 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Adaptimmune Therapeutics
ADAP
|
$64.18 M |
-0.000 M
|
![]() UK
|
![]() bluebird bio
BLUE
|
$43.76 M |
0.000 M
|
![]() USA
|
![]() Cellectis
CLLS
|
$0.18 B |
36.593 M
|
![]() France
|
![]() CRISPR Therapeutics
CRSP
|
$3.34 B |
0.000 M
|
![]() Switzerland
|
![]() Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
![]() USA
|
![]() Fate Therapeutics
FATE
|
$0.13 B |
0.000 M
|
![]() USA
|
![]() Intellia Therapeutics
NTLA
|
$0.76 B |
-0.000 M
|
![]() USA
|
![]() Poseida Therapeutics
PSTX
|
$0.93 B |
0.000 M
|
![]() USA
|
![]() Precision BioSciences
DTIL
|
$57.86 M |
0.000 M
|
![]() USA
|
![]() Sangamo Therapeutics
SGMO
|
$0.17 B |
0.000 M
|
![]() USA
|
Market Cap | = | IMTX Stock Price | * | IMTX Shares Outstanding |
= | $4.37 | * | 0.12 B | |
= | $0.53 B |